J. Ruckle

发表

Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects

F. Gheyas, O. Laterza, J. Wagner, 2018, Journal of clinical pharmacology.

Pharmacokinetics of repaglinide in subjects with renal impairment

T. Marbury, P. Strange, Won‐Chin Huang, 2000, Clinical pharmacology and therapeutics.

Single‐Dose, Randomized, Double‐Blind, Placebo‐Controlled Study of ACE‐011 (ActRIIA‐IgG1) in Postmenopausal Women

Yijun Yang, Ravindra Kumar, J. Seehra, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Multiple-dose pharmacokinetics of fluvoxamine in children and adolescents.

J. Biederman, G. Emslie, J. Ferguson, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study.

H. Synal, K. Wertz, S. Tannenbaum, 2011, The American journal of clinical nutrition.

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

Kevin F. Jones, R. Jordan, J. Leeds, 2012, Antimicrobial Agents and Chemotherapy.

Safety and Pharmacokinetic Profile of Multiple Escalating Doses of (+)-Calanolide A, a Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy HIV-Negative Volunteers

M. Flavin, Ze-Qi Xu, J. Ruckle, 2002, HIV clinical trials.

Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Virus-Negative Human Subjects

M. Flavin, Ze-Qi Xu, J. Ruckle, 2001, Antimicrobial Agents and Chemotherapy.

Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies.

S. W. Halpern, M. Ashburn, W. T. Garland, 2010, Journal of pain and symptom management.

Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans – a practical guide

Tal Burt, Christy S John, Jon L Ruckle, 2017, Expert opinion on drug delivery.

The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.

A. Moses, A. Sommer, D. Clemmons, 2000, The Journal of clinical endocrinology and metabolism.

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males.

W. Zeng, G. Herman, A. Bergman, 2011, British journal of clinical pharmacology.

Bridging Studies in Pharmaceutical Safety Assessment

J. Ruckle, 2010 .

Phase 1 trial of 13‐valent pneumococcal conjugate vaccine in Japanese adults

S. Lockhart, D. Scott, J. Ruckle, 2008, Pediatrics international : official journal of the Japan Pediatric Society.

Effects of laropiprant, a selective prostaglandin D(2) receptor 1 antagonist, on the pharmacokinetics of rosiglitazone.

J. Wagner, M. Stroh, J. Schwartz, 2009, Cardiovascular therapeutics.

A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults.

J. Kemp, J. Ruckle, R. Dixon, 1999, Journal of child and adolescent psychopharmacology.

Use of accelerator mass spectrometry to measure the pharmacokinetics and peripheral blood mononuclear cell concentrations of zidovudine.

Jon L Ruckle, Hans-Arno Synal, Stephen R Dueker, 2008, Journal of pharmaceutical sciences.

BPS804 Anti‐Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

F. Glorieux, F. Jakob, J. Devogelaer, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta : Results of a Randomized Phase 2 a Trial

F. Glorieux, F. Jakob, J. Devogelaer, 2017 .

Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects.

N. Greig, H. Holloway, C. Canfield, 2005, Current Alzheimer research.

First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain

F. Hefti, P. Walicke, Mark T. Brown, 2018, Pain reports.